1,3-Benzodioxolyl-N-ethylbutanamine
 | |
| Clinical data | |
|---|---|
| Other names | 1,3-Benzodioxolyl-N-ethylbutanamine; EBDB; 3,4-Methenedioxy-α,N-diethylphenethylamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | "Probably short"[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO2 |
| Molar mass | 221.300 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 176 to 177 °C (349 to 351 °F) |
| |
| |
| (verify) | |
EBDB, also known as 1,3-benzodioxolyl-N-ethylbutanamine, 3,4-methylenedioxy-α,N-diethylphenethylamine, or ethyl-J, is a psychoactive drug of the phenethylamine, phenylisobutylamine, and MDxx families.[1][2][3] It is the N-ethyl analogue of BDB (J) and the α-ethyl analogue of MDEA.[1]
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists EBDB's minimum dose as 90 mg orally and its duration as unknown.[1] It produced few to no effects at the tested doses.[1]
Chemistry
Synthesis
The chemical synthesis of EBDB has been described.[1]
See also
- Substituted methylenedioxyphenethylamine
- Methylbenzodioxolylbutanamine (MBDB; Methyl-J)
- Ethylbenzodioxolylpentanamine (EBDP; Ethyl-K)
- Eutylone (βk-Ethyl-J)
- Methylenedioxyphenylpropylaminopentane (MPAP)
References
- ^ a b c d e f g Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. Ethyl-J Entry in PiHKAL
- ^ Shulgin A, Manning T, Daley P (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
- ^ Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived from the original on 13 July 2025.